Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California
about
Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzymecovR Mediated Antibiofilm Activity of 3-Furancarboxaldehyde Increases the Virulence of Group A StreptococcusResistance to macrolides in Streptococcus pyogenes in France in pediatric patients.Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 central and Eastern European countriesEmergence of group A streptococcus strains with different mechanisms of macrolide resistanceResistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance.Antistreptococcal activity of telithromycin compared with seven other drugs in relation to macrolide resistance mechanisms in Russia.Erythromycin-resistant group A streptococcal isolates recovered in Sofia, Bulgaria, from 1995 to 2001Disease manifestations and pathogenic mechanisms of Group A Streptococcus.Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance.Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001.Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.Bacitracin-resistant clone of Streptococcus pyogenes isolated from pharyngitis patients in Belgium.Clonal spread of emm type 28 isolates of Streptococcus pyogenes that are multiresistant to antibiotics.Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.Failure of clindamycin to eradicate infection with beta-hemolytic streptococci inducibly resistant to clindamycin in an animal model and in human infections.Antistreptococcal activity of AR-709 compared to that of other agents.Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumonDetection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinationsPrevalence of the erm(T) gene in clinical isolates of erythromycin-resistant group D Streptococcus and Enterococcus.
P2860
Q24609957-12C96916-C28C-4EF9-BE11-FD57C4246BB0Q28547259-53F552EE-3D55-41DE-B5C8-A5099178CE7DQ33979617-9728D5F3-387D-4259-A68E-2566B040045CQ34105515-B338F914-1604-4BEA-AF69-3B5519BA80ABQ34107184-8C96D2FD-6AEB-4015-B701-C2BDD24810CFQ34109184-A1E7DAD4-3FE3-4843-A64E-AD9835A1EE1AQ34112023-75686336-1081-4A9D-97A0-3ABAEC29B6BDQ34202371-98B93F1C-DE21-4C17-B696-292D881E256FQ34413457-5F4CCB10-DC46-4137-972F-A6A8C8E094E0Q34488366-99ED76F3-159F-4A46-9474-A9AD5B8A237AQ35102373-EBA66D75-591B-4FF1-96BF-6E3BBD70EB37Q35548073-AE516A75-26A7-47F2-9388-74136190ABE5Q37059093-4F252249-AE5A-4768-A7A7-5B247D5DD5E4Q37155967-A61E6EB7-7CE4-4AC6-92B3-E0B25195B077Q37420239-9D94E72B-B426-4667-8A48-BE76874D2764Q37643707-BE8D7CA1-1A23-4013-9F81-C142F83D04D4Q38898215-5A876B05-EEAD-4FB3-85A7-71EE44C6E44CQ39478959-B175509C-974E-423A-A7E5-BA956011E0DEQ41016666-55A52B1A-FE17-4ECC-ABDC-C95749AA4BE3Q42111990-06DAB325-C26C-46D8-9062-11389C2EC17F
P2860
Characterization of antimicrobial resistance in Streptococcus pyogenes isolates from the San Francisco Bay area of northern California
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Characterization of antimicrob ...... ay area of northern California
@ast
Characterization of antimicrob ...... ay area of northern California
@en
type
label
Characterization of antimicrob ...... ay area of northern California
@ast
Characterization of antimicrob ...... ay area of northern California
@en
prefLabel
Characterization of antimicrob ...... ay area of northern California
@ast
Characterization of antimicrob ...... ay area of northern California
@en
P2093
P2860
P1476
Characterization of antimicrob ...... ay area of northern California
@en
P2093
Perdreau-Remington F
P2860
P304
P407
P577
1999-06-01T00:00:00Z